human myoblasts cell line Search Results


c2c12  (ATCC)
99
ATCC c2c12
C2c12, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c2c12/product/ATCC
Average 99 stars, based on 1 article reviews
c2c12 - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
primary human skeletal derived myoblasts  (Cook MyoSite Inc)
94
Cook MyoSite Inc primary human skeletal derived myoblasts
Primary Human Skeletal Derived Myoblasts, supplied by Cook MyoSite Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human skeletal derived myoblasts/product/Cook MyoSite Inc
Average 94 stars, based on 1 article reviews
primary human skeletal derived myoblasts - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
skeletal muscle myoblast cell system  (Lonza)
90
Lonza skeletal muscle myoblast cell system
Skeletal Muscle Myoblast Cell System, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/skeletal muscle myoblast cell system/product/Lonza
Average 90 stars, based on 1 article reviews
skeletal muscle myoblast cell system - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human skeletal muscle myoblasts (hsmm) cat. #cc-2580  (Lonza)
90
Lonza human skeletal muscle myoblasts (hsmm) cat. #cc-2580
Human Skeletal Muscle Myoblasts (Hsmm) Cat. #Cc 2580, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human skeletal muscle myoblasts (hsmm) cat. #cc-2580/product/Lonza
Average 90 stars, based on 1 article reviews
human skeletal muscle myoblasts (hsmm) cat. #cc-2580 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human diabetic muscle myoblast (dhsmm) cells  (Lonza)
90
Lonza human diabetic muscle myoblast (dhsmm) cells
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
Human Diabetic Muscle Myoblast (Dhsmm) Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human diabetic muscle myoblast (dhsmm) cells/product/Lonza
Average 90 stars, based on 1 article reviews
human diabetic muscle myoblast (dhsmm) cells - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
heart myocardium cells  (ATCC)
99
ATCC heart myocardium cells
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
Heart Myocardium Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/heart myocardium cells/product/ATCC
Average 99 stars, based on 1 article reviews
heart myocardium cells - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
rat myoblast l6 cells  (ATCC)
96
ATCC rat myoblast l6 cells
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
Rat Myoblast L6 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat myoblast l6 cells/product/ATCC
Average 96 stars, based on 1 article reviews
rat myoblast l6 cells - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
mouse muscle myoblast g 8 cells  (ATCC)
93
ATCC mouse muscle myoblast g 8 cells
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
Mouse Muscle Myoblast G 8 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse muscle myoblast g 8 cells/product/ATCC
Average 93 stars, based on 1 article reviews
mouse muscle myoblast g 8 cells - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
rat skeletal muscle myoblast l 6 cells  (ATCC)
95
ATCC rat skeletal muscle myoblast l 6 cells
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
Rat Skeletal Muscle Myoblast L 6 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat skeletal muscle myoblast l 6 cells/product/ATCC
Average 95 stars, based on 1 article reviews
rat skeletal muscle myoblast l 6 cells - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier
human breast raw264 7 atcc tib 71 mouse macrophage cos07 atcc crl 1651 monkey kidney c2c12 atcc crl 1772 mouse myoblast rko atcc crl  (ATCC)
99
ATCC human breast raw264 7 atcc tib 71 mouse macrophage cos07 atcc crl 1651 monkey kidney c2c12 atcc crl 1772 mouse myoblast rko atcc crl
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
Human Breast Raw264 7 Atcc Tib 71 Mouse Macrophage Cos07 Atcc Crl 1651 Monkey Kidney C2c12 Atcc Crl 1772 Mouse Myoblast Rko Atcc Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human breast raw264 7 atcc tib 71 mouse macrophage cos07 atcc crl 1651 monkey kidney c2c12 atcc crl 1772 mouse myoblast rko atcc crl/product/ATCC
Average 99 stars, based on 1 article reviews
human breast raw264 7 atcc tib 71 mouse macrophage cos07 atcc crl 1651 monkey kidney c2c12 atcc crl 1772 mouse myoblast rko atcc crl - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
c2f3 myoblasts  (ATCC)
96
ATCC c2f3 myoblasts
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
C2f3 Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c2f3 myoblasts/product/ATCC
Average 96 stars, based on 1 article reviews
c2f3 myoblasts - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
recombinant eif5a quail muscle cells  (ATCC)
94
ATCC recombinant eif5a quail muscle cells
Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); <t> human </t> skeletal muscle myoblast (HSMM); diabetic <t> human </t> skeletal muscle myoblast (DHSMM).
Recombinant Eif5a Quail Muscle Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant eif5a quail muscle cells/product/ATCC
Average 94 stars, based on 1 article reviews
recombinant eif5a quail muscle cells - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

Image Search Results


Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); human skeletal muscle myoblast (HSMM); diabetic human skeletal muscle myoblast (DHSMM).

Journal: International Journal of Molecular Sciences

Article Title: Bioactive Ingredients in K. pinnata Extract and Synergistic Effects of Combined K. pinnata and Metformin Preparations on Antioxidant Activities in Diabetic and Non-Diabetic Skeletal Muscle Cells

doi: 10.3390/ijms24076211

Figure Lengend Snippet: Cell viability represented as a percentage of the control after 72 h of treatment. Data are shown as mean ± S.E.M. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); human skeletal muscle myoblast (HSMM); diabetic human skeletal muscle myoblast (DHSMM).

Article Snippet: Human skeletal muscle myoblast (HSMM) and human diabetic muscle myoblast (DHSMM) cells (Lonza, Rockville, MD, USA) were cultured at a concentration of 10 5 cells/mL in skeletal muscle growth media-2 (SkGMTM-2 Medium) containing human Epidermal Growth Factor (hEGF), Dexamethasone, L-glutamine, Fetal Bovine Serum (FBS), Gentamicin/Amphotericin-B (GA), 50 U/mL of penicillin, and 50 mg/mL of streptomycin.

Techniques: Control

Observed cellular superoxide dismutase (SOD) activity in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); human skeletal muscle myoblast (HSMM); diabetic human skeletal muscle myoblast (DHSMM).

Journal: International Journal of Molecular Sciences

Article Title: Bioactive Ingredients in K. pinnata Extract and Synergistic Effects of Combined K. pinnata and Metformin Preparations on Antioxidant Activities in Diabetic and Non-Diabetic Skeletal Muscle Cells

doi: 10.3390/ijms24076211

Figure Lengend Snippet: Observed cellular superoxide dismutase (SOD) activity in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); human skeletal muscle myoblast (HSMM); diabetic human skeletal muscle myoblast (DHSMM).

Article Snippet: Human skeletal muscle myoblast (HSMM) and human diabetic muscle myoblast (DHSMM) cells (Lonza, Rockville, MD, USA) were cultured at a concentration of 10 5 cells/mL in skeletal muscle growth media-2 (SkGMTM-2 Medium) containing human Epidermal Growth Factor (hEGF), Dexamethasone, L-glutamine, Fetal Bovine Serum (FBS), Gentamicin/Amphotericin-B (GA), 50 U/mL of penicillin, and 50 mg/mL of streptomycin.

Techniques: Activity Assay, Control

Observed cellular catalase (CAT) activity in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); human skeletal muscle myoblast (HSMM); diabetic human skeletal muscle myoblast (DHSMM).

Journal: International Journal of Molecular Sciences

Article Title: Bioactive Ingredients in K. pinnata Extract and Synergistic Effects of Combined K. pinnata and Metformin Preparations on Antioxidant Activities in Diabetic and Non-Diabetic Skeletal Muscle Cells

doi: 10.3390/ijms24076211

Figure Lengend Snippet: Observed cellular catalase (CAT) activity in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05): control (no treatment); human skeletal muscle myoblast (HSMM); diabetic human skeletal muscle myoblast (DHSMM).

Article Snippet: Human skeletal muscle myoblast (HSMM) and human diabetic muscle myoblast (DHSMM) cells (Lonza, Rockville, MD, USA) were cultured at a concentration of 10 5 cells/mL in skeletal muscle growth media-2 (SkGMTM-2 Medium) containing human Epidermal Growth Factor (hEGF), Dexamethasone, L-glutamine, Fetal Bovine Serum (FBS), Gentamicin/Amphotericin-B (GA), 50 U/mL of penicillin, and 50 mg/mL of streptomycin.

Techniques: Activity Assay, Control

Reduced glutathione content in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05). Control (No treatment); Human skeletal muscle myoblast (HSMM); Diabetic human skeletal muscle myoblast (DHSMM).

Journal: International Journal of Molecular Sciences

Article Title: Bioactive Ingredients in K. pinnata Extract and Synergistic Effects of Combined K. pinnata and Metformin Preparations on Antioxidant Activities in Diabetic and Non-Diabetic Skeletal Muscle Cells

doi: 10.3390/ijms24076211

Figure Lengend Snippet: Reduced glutathione content in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05). Control (No treatment); Human skeletal muscle myoblast (HSMM); Diabetic human skeletal muscle myoblast (DHSMM).

Article Snippet: Human skeletal muscle myoblast (HSMM) and human diabetic muscle myoblast (DHSMM) cells (Lonza, Rockville, MD, USA) were cultured at a concentration of 10 5 cells/mL in skeletal muscle growth media-2 (SkGMTM-2 Medium) containing human Epidermal Growth Factor (hEGF), Dexamethasone, L-glutamine, Fetal Bovine Serum (FBS), Gentamicin/Amphotericin-B (GA), 50 U/mL of penicillin, and 50 mg/mL of streptomycin.

Techniques: Control

Cellular MDA concentrations in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05). Control (No treatment); Human skeletal muscle myoblast (HSMM); Diabetic human skeletal muscle myoblast (DHSMM).

Journal: International Journal of Molecular Sciences

Article Title: Bioactive Ingredients in K. pinnata Extract and Synergistic Effects of Combined K. pinnata and Metformin Preparations on Antioxidant Activities in Diabetic and Non-Diabetic Skeletal Muscle Cells

doi: 10.3390/ijms24076211

Figure Lengend Snippet: Cellular MDA concentrations in cells after 72 h of treatment. Data are presented as mean ± standard error of the mean. Significant differences are indicated by different letters (uppercase letters within row; lowercase letter within column for each treatment option) according to Tukey post hoc test ( p < 0.05). Control (No treatment); Human skeletal muscle myoblast (HSMM); Diabetic human skeletal muscle myoblast (DHSMM).

Article Snippet: Human skeletal muscle myoblast (HSMM) and human diabetic muscle myoblast (DHSMM) cells (Lonza, Rockville, MD, USA) were cultured at a concentration of 10 5 cells/mL in skeletal muscle growth media-2 (SkGMTM-2 Medium) containing human Epidermal Growth Factor (hEGF), Dexamethasone, L-glutamine, Fetal Bovine Serum (FBS), Gentamicin/Amphotericin-B (GA), 50 U/mL of penicillin, and 50 mg/mL of streptomycin.

Techniques: Control